These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 33161252

  • 1. Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors.
    Mohamed MFA, Marzouk AA, Nafady A, El-Gamal DA, Allam RM, Abuo-Rahma GEA, El Subbagh HI, Moustafa AH.
    Bioorg Chem; 2020 Dec; 105():104439. PubMed ID: 33161252
    [Abstract] [Full Text] [Related]

  • 2. Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction.
    Ibrahim TS, Moustafa AH, Almalki AJ, Allam RM, Althagafi A, Md S, Mohamed MFA.
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1067-1078. PubMed ID: 34027787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
    Abd-Ellah HS, Abdel-Aziz M, Shoman ME, Beshr EA, Kaoud TS, Ahmed AF.
    Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
    [Abstract] [Full Text] [Related]

  • 7. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
    Abd-Ellah HS, Abdel-Aziz M, Shoman ME, Beshr EAM, Kaoud T, Ahmed AFF.
    Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA.
    Eur J Med Chem; 2019 Jun 01; 171():25-37. PubMed ID: 30904755
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study.
    Hegazy ME, Taher ES, Ghiaty AH, Bayoumi AH.
    Bioorg Chem; 2024 Apr 01; 145():107244. PubMed ID: 38428284
    [Abstract] [Full Text] [Related]

  • 15. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM, Abdelmoez AAB, Tarazi H, El-Shorbagi AA, El-Awady R.
    Bioorg Chem; 2020 Jan 01; 94():103378. PubMed ID: 31677858
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 01; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G, Ramana KV, Sudhana SM, Rao DS, Kumar KH, Lokanatha V, Rani AU, Raju CN.
    Med Chem; 2017 May 01; 13(5):484-497. PubMed ID: 28228088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.